PL

PloS one

2026-01-01

Internetowa rehabilitacja przedsionkowa vs. pisemne instrukcje po ostrym zawrocie głowy: randomizowane badanie kontrolne

Internet-based vestibular rehabilitation versus written instructions after acute vertigo: A randomised controlled trial.

Surano Solmaz, Lindell Ellen, Mathé Jan, Davidsson Hugo, Tomanovic Tatjana, Bjurman Maria, Faergemann Erik, Ledin Torbjörn, Rostmark Anette, Grip Helena, Öhberg Fredrik, Granåsen Gabriel, Salzer Jonatan

Recenzja AI

Cel badania

Celem badania było porównanie skuteczności internetowej rehabilitacji przedsionkowej z tradycyjnymi pisemnymi instrukcjami w redukcji objawów przedsionkowych po ostrym zawrocie głowy.

Metoda

Przeprowadzono wieloośrodkowe, randomizowane badanie kontrolne z podwójnie ślepą próbą w dziewięciu szpitalach w Szwecji, w którym uczestnicy byli losowo przydzielani do dwóch grup przez sześć tygodni.

Wyniki

Wyniki pokazały, że obie grupy poprawiły się po sześciu tygodniach, jednak nie stwierdzono istotnych różnic między grupami w zakresie objawów przedsionkowych.

Znaczenie dla praktyki

Wyniki sugerują, że dostęp do ćwiczeń rehabilitacyjnych może być ważniejszy niż forma ich dostarczania, co może mieć istotne znaczenie dla praktyki klinicznej w Polsce, zwłaszcza w kontekście pacjentów preferujących cyfrowe rozwiązania.

Abstrakt oryginalny

BACKGROUND: Acute vestibular syndrome (AVS) causes sudden and continuous vertigo, dizziness, and postural instability and is a common reason for emergency department visits, most commonly due to vestibular neuritis and, in rare cases, stroke. Vestibular rehabilitation (VR) is an evidence-based exercise therapy that facilitates vestibular compensation and is effective in chronic vestibular disorders. However, evidence for VR in acute vertigo remains limited and, despite guideline support, it remains underused in practice. Internet-based VR has demonstrated benefit in chronic dizziness but has not been evaluated in acute vertigo. This study aimed to evaluate the efficacy of an internet-based VR tool compared with standard care (written instructions) in reducing vestibular symptoms after acute onset vertigo. METHODS AND FINDINGS: A multicentre, randomised, evaluator-blinded superiority trial was conducted across nine hospitals in Sweden. Adults with ongoing AVS were recruited within 1-7 days after symptom onset and randomised (1:1) to six weeks of internet-based VR with personalised, progressively adjusted home exercises or to written instructions for home-based VR exercises. The primary outcome was the between-group difference in vestibular symptoms at six weeks measured using the Vertigo Symptom Scale Short Form (VSS-SF; range 0-60), with a difference of ≥3 points prespecified as clinically significant. Secondary outcomes included dizziness-related disability, walking speed, and balance. Of 184 randomised participants, 183 were included in the analyses (94 online VR; 89 written instructions; median age 56 years). In the intention-to-treat analysis, both groups improved at six weeks, with no significant between-group difference (adjusted mean difference -2.0 points, 95% CI -4.9 to 0.9; p = 0.18). Per-protocol analyses were consistent (-1.7 points, 95% CI -4.7 to 1.3; p = 0.27). Over 12 weeks, both groups showed reduced vestibular symptoms and improved disability, balance, and walking speed, without significant between-group differences. No serious adverse events were attributed to the interventions, and compliance was high in both groups. CONCLUSIONS: Internet-based VR was not superior to written instructions in reducing vestibular symptoms six weeks after acute onset vertigo. Both groups demonstrated improvement from baseline, with no statistically significant between-group differences. These findings suggest that ensuring access to vestibular rehabilitation exercises may be more important than the specific mode of delivery after acute onset vertigo, and internet-based tools represent viable alternatives for patients who prefer or may benefit from a digital format. TRIAL REGISTRATION: Clinicaltrials.gov NCT05056324. https://clinicaltrials.gov/study/NCT05056324. Registered on September 24, 2021.

Źródło

PL

PloS one

2026-01-01

DOI: 10.1371/journal.pone.0351092

PMID: 42284306

PubMed Pełny tekst

Autorzy (13)

Surano SolmazLindell EllenMathé JanDavidsson HugoTomanovic TatjanaBjurman MariaFaergemann ErikLedin TorbjörnRostmark AnetteGrip HelenaÖhberg FredrikGranåsen GabrielSalzer Jonatan
StartSzukaj